Search
Subscribe for $1
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
biogen
biogen
Biogen (BIIB) Q4 2025 Earnings Call Transcript
By
Fortune Editors
February 6, 2026
Biogen (BIIB) Q3 2025 Earnings Call Transcript
By
Fortune Editors
October 30, 2025
Biogen (BIIB) Q2 2025 Earnings Call Transcript
By
Fortune Editors
July 31, 2025
Biogen (BIIB) Q1 2025 Earnings Call Transcript
By
Fortune Editors
May 1, 2025
Biogen (BIIB) Q4 2024 Earnings Call Transcript
By
Fortune Editors
February 12, 2025
Newsletters
Will vaccine mandates worsen the ongoing health care shortage?
By
Yasmin Tayag
September 30, 2021
Newsletters
The science behind a fond farewell
By
Sy Mukherjee
September 23, 2021
Newsletters
Offices, employees, and customers: The COVID mask conundrum
By
Sy Mukherjee
July 29, 2021
Newsletters
The never ending Biogen Alzheimer’s drug saga delivers yet another twist
By
Sy Mukherjee
July 8, 2021
Health
Biogen makes a drastic move, as doctors refuse to prescribe its controversial Alzheimer’s drug
By
Sy Mukherjee
July 8, 2021
Health
Pressure mounts on Biden to nominate permanent FDA head as dissatisfaction with agency grows
By
Sy Mukherjee
June 22, 2021
Health
Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By
Sy Mukherjee
June 9, 2021
Health
FDA approves Biogen’s controversial Alzheimer’s drug in historic decision
By
Sy Mukherjee
June 7, 2021
Health
President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By
Sy Mukherjee
May 25, 2021
Health
It’s the New Year, and pharma companies are already hiking prices for popular drugs
By
Sy Mukherjee
January 4, 2021
Most Popular
Success
Japanese companies are paying older workers to sit by a window and do nothing—while Western CEOs demand super-AI...
By
Orianna Rosa Royle
AI
The week the AI scare turned real and America realized maybe it isn't ready for what's coming
By
Nick Lichtenberg
Middle East
Iran is now on 'death ground' amid existential threat from U.S. attacks and could 'go big' in retaliation, former NATO...
By
Jason Ma